The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Things like Interleukin 1 beta, things like C-reactive protein, things like interleukin 6. Interleukin 6 is kind of the generic inflammatory marker that all studies refer to. And yet there are other interleukins, please note that there are other interleukins like interleukin 10 that are anti-inflammatory.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.